A mini-review on novel intraperiodontal pocket drug delivery materials for the treatment of periodontal diseases

Drug Delivery and Translational Research

Volumn 4, Issue 3, 2014, Pages 295-301

  Hau, H ^a   Rohanizadeh, R ^a   Ghadiri, M ^a   Chrzanowski, W ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antimicrobial agents; Clay; Local drug delivery; Periodontal disease; Polymer gel

Indexed keywords

ANTIBIOTIC AGENT; CALCIUM PHOSPHATE DIBASIC; CEMENT; DOXYCYCLINE; IBUPROFEN; METRONIDAZOLE; METRONIDAZOLE BENZOATE; TETRACYCLINE; TIMOLOL MALEATE;

ALVEOLAR BONE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; COMPARATIVE STUDY; CONNECTIVE TISSUE; DRUG DELIVERY DEVICE; DRUG DELIVERY SYSTEM; DRUG EXPOSURE; DRUG FORMULATION; DRUG RELEASE; GEL; HUMAN; NONHUMAN; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTITIS; PRIORITY JOURNAL; REVIEW; SYSTEMIC THERAPY;

EID: 84900015206     PISSN: 2190393X     EISSN: 21903948     Source Type: Journal    
DOI: 10.1007/s13346-013-0171-x     Document Type: Review

References (37)

1. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366: 1809-20.
2. Medlicott NJ, Rathbone MJ, Tucker IG, Holborow DW. Delivery systems for the administration of drugs to the periodontal pocket. Adv Drug Del Rev. 1994;13: 181-203.
3. Albandar JM, Rams TE. Global epidemiology of periodontal diseases: an overview. Periodontology. 2000;2002(29): 7-10.
4. Soskolne WA, Chajek T, Flashner M, Landau I, Stabholtz A, Kolatch B, et al. An in vivo study of the chlorhexidine release profile of the PerioChip (TM) in the gingival crevicular fluid, plasma and urine. J Clin Periodontol. 1998;25: 1017-21.
5. Jain N, Jain GK, Javed S, Iqbal Z, Talegaonkar S, Ahmad FJ, et al. Recent approaches for the treatment of periodontitis. Drug Discov Today. 2008;13: 932-43.
6. Drisko CH. Nonsurgical periodontal therapy. Periodontology. 2000;2001(25): 77-88.
7. Schwach-Abdellaoui K, Vivien-Castioni N, Gurny R. Local delivery of antimicrobial agents for the treatment of periodontal diseases. Eur J Pharm Biopharm. 2000;50: 83-99.
8. Walker C, Karpinia K. Rationale for use of antibiotics in periodontics. J Periodontol. 2002;73: 1188-96.
9. Marsh PD. Plaque as a biofilm: pharmacological principles of drug delivery and action in the sub- and supragingival environment. Oral Dis. 2003;9 Suppl 1: 16-22.
10. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001;358: 135-8.
11. Dabhi MR, Nagori SA, Gohel MC, Parikh RK, Sheth NR. Formulation development of smart gel periodontal drug delivery system for local delivery of chemotherapeutic agents with application of experimental design. Drug Deliv. 2010;17: 520-31.
12. Goodson JM. Pharmacokinetic principles controlling efficacy of oral-therapy. J Dent Res. 1989;68: 1625-32.
13. SaTCotAAoP R. The role of controlled drug delivery for periodontitis. J Periodontol. 2000;71: 125-40.
14. Goodson JM, Haffajee A, Socransky SS. Periodontal therapy by local-delivery of tetracycline. J Clin Periodontol. 1979;6: 83-92.
15. Mundargi RC, Srirangarajan S, Agnihotri SA, Patil SA, Ravindra S, Setty SB, et al. Development and evaluation of novel biodegradable microspheres based on poly(d, l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: In vitro and in vivo studies. J Control Release. 2007;119: 59-68.
16. Balamurugan A, Balossier G, Laurent-Maquin D, Pina S, Rebelo AHS, Faure J, et al. An in vitro biological and anti-bacterial study on a sol-gel derived silver-incorporated bioglass system. Dent Mater. 2008;24: 1343-51.
17. Aguzzi C, Cerezo P, Viseras C, Caramella C. Use of clays as drug delivery systems: possibilities and limitations. Appl Clay Sci. 2007;36: 22-36.
18. Bland PS, Goodson JM, Gunsolley JC, Grossi SG, Otomo-Corgel J, Doherty F, et al. Association of antimicrobial and clinical efficacy: periodontitis therapy with minocycline microspheres. J Int Acad Periodontol. 2010;12: 11-9.
19. Kinane DF. Local antimicrobial therapies in periodontal disease. Ann R Australas Coll Dent Surg. 2000;15: 57-60.
20. Norling T, Lading P, Engstrom S, Larsson K, Krog N, Nissen SS. Formulaton of drug delivery system based on a mixture of monoglycerides and triglycerides for use in the treament of periodontal-disease. J Clin Periodontol. 1992;19: 687-92.
21. Reise M, Wyrwa R, Mueller U, Zylinski M, Voelpel A, Schnabelrauch M, et al. Release of metronidazole from electrospun poly(l-lactide-co-d/l-lactide) fibers for local periodontitis treatment. Dent Mater. 2012;28: 179-88.
22. Schwach-Abdellaoui K, Monti A, Barr J, Heller J, Gurny R. Optimization of a novel bioerodible device based on auto-catalyzed poly(ortho esters) for controlled delivery of tetracycline to periodontal pocket. Biomaterials. 2001;22: 1659-66.
23. Tamimi F, Torres J, Bettini R, Ruggera F, Rueda C, Lopez-Ponce M, et al. Doxycycline sustained release from brushite cements for the treatment of periodontal diseases. J Biomed Mater Res A. 2008;85: 707-14.
24. Vyas SP, Sihorkar V, Mishra V. Controlled and targeted drug delivery strategies towards intraperiodontal pocket diseases. J Clin Pharm Ther. 2000;25: 21-42.
25. Yue IC, Poff J, Cortes ME, Sinisterra RD, Faris CB, Hildgen P, et al. A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease. Biomaterials. 2004;25: 3743-50.
26. Heller J, Barr J, Ng SY, Shen HR, Schwach-Abdellaoui K, Gurny R, et al. Development and applications of injectable poly(ortho esters) for pain control and periodontal treatment. Biomaterials. 2002;23: 4397-404.
27. Schwach-Abdellaoui K, Loup PJ, Vivien-Castioni N, Mombelli A, Baehni P, Barr J, et al. Bioerodible injectable poly(ortho ester) for tetracycline controlled delivery to periodontal pockets: preliminary trial in humans. AAPS PharmSci. 2002;4: E20.
28. Ji QX, Zhao QS, Deng J, Lu R. A novel injectable chlorhexidine thermosensitive hydrogel for periodontal application: preparation, antibacterial activity and toxicity evaluation. J Mater Sci Mater Med. 2010;21: 2435-42.
29. Pandit N, Dahiya R, Gupta R, Bali D, Kathuria A. Comparative evaluation of locally delivered minocycline and metronidazole in the treatment of periodontitis. Contemp Clin Dent. 2013;4: 48-53.
30. Tamimi F, Sheikh Z, Barralet J. Dicalcium phosphate cements: brushite and monetite. Acta Biomater. 2012;8: 474-87.
31. Alani A, Knowles JC, Chrzanowski W, Ng YL, Gulabivala K. Ion release characteristics, precipitate formation and sealing ability of a phosphate glass-polycaprolactone-based composite for use as a root canal obturation material. Dent Mater. 2009;25: 400-10.
32. Bohner M, Lemaitre J, van Landuyt P, Zambelli PY, Merkle HP, Gander B. Gentamicin-loaded hydraulic calcium phosphate bone cement as antibiotic delivery system. J Pharm Sci. 1997;86: 565-72.
33. Young AM, Ng PYJ, Gbureck U, Nazhat SN, Barralet JE, Hofmann MP. Characterization of chlorhexidine-releasing, fast-setting, brushite bone cements. Acta Biomater. 2008;4: 1081-8.
34. Joshi GV, Kevadiya BD, Patel HA, Bajaj HC, Jasra RV. Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate. Int J Pharm. 2009;374: 53-7.
35. Zheng JP, Luan L, Wang HY, Xi LF, Yao KD. Study on ibuprofen/montmorillonite intercalation composites as drug release system. Appl Clay Sci. 2007;36: 297-301.
36. Xu SW, Zheng JP, Tong L, Yao KD. Interaction of functional groups of gelatin and montmorillonite in nanocomposite. J Appl Polym Sci. 2006;101: 1556-61.
37. Eggert FM, Drewell L, Bigelow JA, Speck JE, Goldner M. The pH of gingival crevices and periodontal pockets in children, teenagers and adults. Arch Oral Biol. 1991;36: 233-8.